SCOTT JORDAN
Founder / CEO
S. Jordan Associates (SJA) is a Strategic Advisory / Investment Bank located in Chicago, Illinois.
S. Jordan Associates (SJA) is led by Scott Jordan, a FINRA licensed registered representative with over 30 years of experience in the life sciences industry as a C-Level / business development executive, and investment banker. During this time, Scott successfully assisted biotechnology companies raise private placements / secondary public stock offerings, secure regional / global licensing agreements, and facilitate liquidity events via M&A, and initial / alternative public offerings.
In addition to Scott’s role as CEO/ Founder of SJA, he is the Chief Financial Officer (CFO) of Inomagen Therapeutics which is developing a gene therapy for the treatment of atrial fibrillation and Advisor to AUM Biosciences (small molecule / tyrosine kinase inhibitors), ImaginAb (radiopharmaceuticals), and Meditope Biosciences (ADC linker technology).
Previously, Scott was Chief Business Officer (CBO) / CFO of two early-stage companies located in Houston, Texas (Iterion Therapeutics, Salarius Pharmaceuticals) supported by non-dilutive financing from the Cancer Prevention Research Institute of Texas (CPRIT). Scott’s efforts at Salarius including raising Series 1 / A financing rounds advancing the company’s lead asset into Phase 1 / 2 clinical trials in a rare, Orphan disease (Ewing Sarcoma). As a result of the company achieving pivotal financing and scientific milestones, Salarius listed on NASDAQ via a reverse merger with Flex Pharma, Inc in July of 2019.
In addition to his leadership roles at Iterion and Salarius, Scott also worked closely with a promising immune-oncology company, Stingray Therapeutics, founded by Dr. Sunil Sharma – Physician in Chief, Division Director Applied Cancer Research and Drug Discovery. In January of 2024, Stingray was awarded a $13.8M CPRIT award to evaluate SR-8541A plus balstilimab and botensilimab in micro-satellite stable (MSS) colorectal cancer.
Scott also worked at Healthios Capital Markets LLC, a boutique investment bank serving the life sciences industry including private placements and mergers and acquisitions (M&A). Since 2005 including during his tenure with Healthios, Scott raised $153M of private placements and $67M of non-dilutive capital (CPRIT, NIH), closed $583M in licensing deals, and secured $194M via public offerings (IPO / Reverse Merger).
Scott is a Level II Candidate in the Chartered Financial Analyst (CFA) Program. Scott holds Series 7, 66, 63 & 31 licenses.
Securities are offered through Finalis Securities LLC Member FINRA/SIPC.
S. Jordan Associates and Finalis Securities LLC are separate, unaffiliated entities.
CHRIS LEHMAN
Investment Banker
A seasoned financial and business development executive in the life sciences sector, [Name] brings over 25 years of leadership experience spanning venture-backed private and public companies across therapeutics, diagnostics, CRO, and industrial biotech. With a unique blend of strategic partnering and financial expertise, [Name] has successfully led or supported more than 28 partnering and financing transactions totaling $950 million.
Throughout his career, he has leveraged a deep global network of investment banks, venture capital firms, equity research analysts, and strategic pharmaceutical partners to raise both dilutive and non-dilutive capital. His track record includes delivering investor presentations and forging partnerships across the United States, Europe, and Asia. In addition, he founded and scaled a successful strategic advisory firm, completing over 20 client engagements with emerging and growth-stage life sciences companies.
COREY MENDOZA
Chief Marketing Strategist & Emmy Award-Winning Producer
Corey Mendoza is an Emmy Award-winning producer and multidisciplinary marketing strategist with a proven track record of driving visibility, trust, and capital across biotech, healthcare, investment banking, and luxury real estate. With over two decades of experience, Corey partners directly with founders, executives, and investor relations teams to craft and execute end-to-end brand strategies that accelerate growth and fundraising.
His expertise spans strategic messaging, visual branding, investor communications, social media, video production, and campaign development—all tailored to high-stakes audiences. From supporting multi-million dollar biotech raises (Reg D, Reg CF, IPO) to repositioning real estate groups as market leaders, Corey delivers full-scale creative solutions that translate complex science, financial vision, and brand value into measurable results.
Recent collaborations include work with emerging gene therapy and regenerative medicine companies, nationally ranked real estate teams, and alternative investment platforms. Whether launching a new therapeutic platform or elevating a high-net-worth brand, Corey blends cinematic storytelling with strategic precision—transforming innovation into influence.
AWARDS:
(5) Emmy Awards for "Minds of Medicine & "Vital Signs" (NATAS/Mid-Atlantic)
(3) Telly Awards for “Best Production” in Television - “Gold Coast Reality"
(3) Axiem Awards for "Absolute eXcellence" in Digital Media
(2) Silver Mic Awards for Advertising Commercials
(1) New York Film Festival Award for "Best Documentary" for the film, "Worth It All"
(1) MarCom Creative for regional Advertising Campaign